Share
Industrial Technology - Linked-in Industrial Technology - Twitter Industrial Technology - News Feed
Latest Issue
Diary and Events

Sensors & Instrumentation Live

NEC Birmingham(B40 1NT)

25/09/2019 - 26/09/2019

Sensors & Instrumentation Live will celebrate its 10 year anniversary in 2019 and the UK’s (more)

PPMA Show 2019

NEC, Birmingham(B40 1NT)

01/10/2019 - 03/10/2019

The UK’s largest ever event in the processing and packaging sector calendar. With over 350 exhibitors (more)

Advanced Engineering 2019

NEC, Birmingham(B40 1NT)

30/10/2019 - 31/10/2019

The UK's largest annual advanced manufacturing trade show, Advanced Engineering is your opportunity to (more)

Using automation to help reduce patients' suffering

Using automation to help reduce patients' suffering Traditional methods of pan-retinal laser photocoagulation to treat retinal diseases caused by diabetes have changed little in the past 35 years. Laser photocoagulation involves the controlled destruction of the peripheral retina using targeted laser pulses. While this type of treatment has proven effective at reducing the chances of vision loss by as much as 50 percent, it can be very tedious to both patients and doctors. Ophthalmologists can deliver only one burn at a time, and treatment can require as many as 2,000 burns. A full course of treatment typically requires two to four sessions, each lasting 12 to 15 minutes. OptiMedica specialises in the design of medical devices that help ophthalmologists improve the way retinal disease is treated. The company's most recent design is the PASCAL (pattern scan laser) photocoagulator, developed to be a fully integrated pattern scanning laser system that provides significantly improved performance for the physician administering the treatment, as well as an enhanced therapeutic experience for the patient. Photocoagulation is a proven procedure that has been manually administered for many years to improve the lives of patients suffering from diabetic retinopathy. Using LabVIEW FPGA technology, OptiMedica has been able to automate this proven procedure with speed and reliability. The PASCAL photocoagulator successfully reduces treatment duration as well as patient discomfort. It also can reduce the number of treatment sessions, thereby reducing costs to both doctors and patients and making it very popular among lead users.
 

Other News from National Instruments

Subaru reduces vehicle test development times by 90%

Latest news about Sensors and systems

Additional Information
Text styles